With more than 89 million chronic disease sufferers in the US alone, NetScienctific is focused on fighting chronic diseases on three fronts to create 'next generation healthcare technologies'. Thier healthcare investment strategy is building businesses in digital health, diagnostics and therapeutics. Summer Parks of PharmaVentures interviews Francois Martelet, CEO of NetScientific at Biotech and Money World Congress in London.